Interní Med. 2003; 5(2): 83-85

Santax - farmakologický profil

MUDr. Jiří Slíva
Ústav farmakologie 3. LF UK, Praha

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slíva J. Santax - farmakologický profil. Interní Med. 2003;5(2):83-85.

Úvod

Průjem není samostatné onemocnění. Jedná se o symptom, který bývá nejčastěji charakterizován jako časté vyprazdňování řídké a neformované stolice. Čistě etiologicky může být průjem, tedy diarrhoea, dělen na průjem infekční a neinfekční...

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aldemir M. Kokoglu O F.; Geyik, M. F.; Buyukbayram, H. Effects of octreotide acetate and Saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med 2002; 198: 1-9. Go to original source... Go to PubMed...
    2. Boddy AV, Elmer GW, McFarland LV, Levy RH. Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats. Pharm Res 1991; 8: 796-800. Go to original source... Go to PubMed...
    3. Brar HS, Surawicz CM. Pseudomembranous colitis: an update. Can J Gastroenterol 2000; 14: 51-56. Go to original source... Go to PubMed...
    4. Caetano JA, Parames MT, Babo MJ, Santos A, Ferreira AB, Freitas AA, Coelho MR, Mateus AM. Immunopharmacological effects of Saccharomyces boulardii in healthy human volunteers. Int J Immunopharmacol 1986; 8: 245-259. Go to original source... Go to PubMed...
    5. Czerucka D, Nano JL, Bernasconi P, Rampal P. Response to cholera toxin of 2 epithelial intestinal cell lines. Effect of Saccharomyces boulardii. Gastroenterol Clin Biol 1989; 13: 383-387. Go to PubMed...
    6. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324: 1361. Go to original source... Go to PubMed...
    7. Kirchhelle A, Fruhwein N, Toburen, D. Treatment of persistent diarrhea with S. boulardii in returning travelers. Results of a prospective study. Fortschr Med 1996; 114: 136-140. Go to PubMed...
    8. Lherm T, Monet C, Nougiere B, Soulier M, Larbi D, Le Gall C, Caen D, Malbrunot C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002; 28: 797-801. Go to original source... Go to PubMed...
    9. Line JE, Bailey JS, Cox NA, Stern NJ, Tompkins T. Effect of yeast-supplemented feed on Salmonella and Campylobacter populations in broilers. Poult Sci 1998; 77: 405-410. Go to original source... Go to PubMed...
    10. Muller J, Remus N, Harms KH. Mycoserological study of the treatment of paediatric cystic fibrosis patients with Saccharomyces boulardii (Saccharomyces cerevisiae Hansen CBS 5926). Mycoses 1995; 38: 119-123. Go to original source... Go to PubMed...
    11. Peret Filho LA, Penna FJ, Bambirra EA, Nicoli JR. Dose effect of oral Saccharomyces boulardii treatments on morbidity and mortality in immunosuppressed mice. J Med Microbiol 1998; 47: 111-116. Go to original source... Go to PubMed...
    12. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 2000; 95: S11-S13. Go to original source... Go to PubMed...
    13. Riquelme AJ, Calvo MA, Guzman AM, Depix MS, Garcia P, Perez C, Arrese M, Labarca JA. Saccharomyces cerevisiae Fungemia After Saccharomyces boulardii Treatment in Immunocompromised Patients. J Clin Gastroenterol 2003; 36: 41-43. Go to original source... Go to PubMed...
    14. Viggiano M, Badetti C, Bernini V, Garabedian M, Manelli JC. Saccharomyces boulardii fungemia in a patient with severe burns. Ann Fr Anesth Reanim 1995; 14: 356-358. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.